HUAWEI
During the Huawei Day 0 Forum at MWC Barcelona 2022, Huawei released a series of new IT products and solutions as part of a new "intelligent IT foundation" for operators. David Wang, Executive Director of the Board and Chairman of the ICT Infrastructure Managing Board at Huawei, explained in his keynote speech titled "+IT, New Growth" that this reliable and efficient IT foundation will help operators go intelligent, increase revenue, reduce costs, boost efficiency, and ultimately achieve new growth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220228005736/en/
With the rapid development of emerging technologies like 5G, IoT, cloud computing, and intelligence, operators have put their own digital transformations at the top of their agendas so that they can later help other B2B industries to go digital. This kind of transformation however requires IT infrastructure upgrades, multi-cloud collaboration, and quick market wins to generate more momentum.
Wang explained that Huawei's intelligent IT foundation is specifically designed to help operators meet these new requirements. This foundation includes a fully-collaborative distributed cloud and an all-scenario data pool.
At the same event, Huawei also launched the industry's first ever distributed, cloud-native solution. This fully-collaborative cloud helps operators to achieve ICT orchestration, cloud-network synergy, and cloud-edge synergy. The architecture supports both data and media platforms as a service for operators and application platform as a service (aPaaS) for industry customers. This delivers guaranteed experiences for app users unlimited by geography, multi-cloud collaboration, and data traffic. The company currently says that one day, it hopes to offer everything as a service.
Huawei also announced a new series of data infrastructure products as part of its OneStorage strategy to support continual storage evolution. As data types continue to diversify, applications have become more affordable and data protection is more important than ever. Huawei's OneStorage solution gives operators the efficiency they need to meet these requirements through on-demand resource provisioning, intelligent data management, and multi-cloud convergence. It is currently Huawei's best offering for operators who want to keep their data infrastructure up-to-date and explore new businesses.
By the end of 2021, HUAWEI CLOUD and its partners had built 61 availability zones in 27 areas to serve more than 170 countries and regions. It has also started working with more than 120 operators in the cloud service market to help enterprise customers go digital. It currently offers more than 50 scenario-specific cloud services for nine vertical markets, such as manufacturing, retail, and healthcare, to go digital. These intelligent and efficient data storage services offerings are currently used by 300 operators worldwide and the OceanStor Dorado solution has been named a Leader in Gartner's Magic Quadrant for six years in a row.
Reliable, efficient, and intelligent IT infrastructure is critical for operators to go digital. Huawei wants to continue working with operators to roll out IT infrastructure, help industry go digital, and achieve new growth together.
MWC22 Barcelona will run from February 28 to March 3 in Barcelona, Spain. Huawei will showcase its products and solutions at stand 1H50 in Fira Gran Via Hall 1. Together with global operators, industry professionals, and opinion leaders, we will dive into topics such as industry trends, GUIDE to the Future, and green development to envision the future of digital networks. For more information, please visit: https://carrier.huawei.com/en/events/mwc2022 .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005736/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom